| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.01 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.01 |